![](https://monteverdelaw.com/wp-content/uploads/case-logo/homology-medicines-inc.png)
Homology Medicines, Inc. (Nasdaq: FIXX), relating to its proposed merger with Q32 Bio, Inc. Under the terms of the agreement, FIXX shareholders are expected to own approximately 25% of the combined company.
Homology Medicines, Inc. (Nasdaq: FIXX), relating to its proposed merger with Q32 Bio, Inc. Under the terms of the agreement, FIXX shareholders are expected to own approximately 25% of the combined company.